| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.33 | 2e-06 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.14 | 9e-06 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.22 | 2e-05 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.23 | 3e-05 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.19 | 4e-05 |
| mRNA | Docetaxel | GDSC1000 | pan-cancer | AAC | -0.13 | 5e-05 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0004 |